Business
OWC Pharmaceutical Research Announces the Promising Results of Phase Lab Testing for Multiple Myeloma
OWC Pharmaceutical Research Announces the Promising Results of Phase Lab Testing for Multiple Myeloma.
About this update from Owc Pharmaceutical Research Corp
[{"type":"text","content":"\n\n\n\nOWC Pharmaceutical Research Announces the Promising Results of Phase Lab Testing for Multiple Myeloma\n\n\n\n\n\nOWC Pharmaceutical Research Announces the Promising Results of Phase Lab Testing for Multiple Myeloma\nClinical Study to Begin upon approval of IRB for Clinical Phase\nPR Newswire\nPETACH TIKVA, Israel, June 17, 2015\n\n\n\nPETACH TIKVA, Israel, June 17, 2015 /PRNewswire/ --\n\nOWC Pharmaceutical Research Corp. (OTCQB: OWCP), today announced that its wholly owned subsidiary, One World Cannabis Ltd. (\"the Company\"), an Israel-based developer of cannabinoid-based therapies targeting a variety of different indications, is proud to announce it has received the first basic science study (lab) results on the effect of several combination of Cannabidiol (CBD) and tetrahydrocannabinol (THC) on multiple myeloma cell line RPMI8226.\n\n     (Logo: http://photos.prnewswire.com/prnh/20150311/734965-a )\n\n\n     (Logo: http://photos.prnewswire.com/prnh/20150311/734965-b )\n\n\n\nBased on the results, One World Cannabis will submit the clinical trial protocol to the IRB (Helsinki committee). The company expects to receive institutional review board approval for the study within 6-9 weeks.\n\nThe OWC multiple myeloma study was done by three repetitive tests on the effect of cannabis extract with various combination ratios of THC/CBD and pure THC and CBD (50% concentration). The results present more than 60% malignant cell death. More results of pure THC and CBD are under further analysis.\n\nMultiple myeloma cells were cultured for 48 hours with CBD and THC (all cannabis extracts) as compare to their combinations - CBD: THC 1:1; CBD: THC 5:1 and CBD: THC 1:5. Combination Index (CI) value <1, =1, >1 indicates synergism, additive effect, and antagonism, respectively. Each treatment was performed in triplicate in four independent experiments and presented as mean. The treatment of CBD in combination with THC had synergistic effect, being their cytotoxic effect is higher with each of the three combinations tested.\n\nCBD and THC decreased survival of multiple myeloma cells in a concentration-dependent manner.\n\nTo download the RPMIS multiple myeloma cell line graph and logos visit OWC's newsroom.\n\nMultiple myeloma, a cancer of plasma cells in the bone marrow, accounts for 10% of...